Login / Signup

ICON 2023: International Scientific Tendinopathy Symposium Consensus - the core outcome set for Achilles tendinopathy (COS-AT) using a systematic review and a Delphi study of professional participants and patients.

Robert-Jan de VosKarin Gravare SilbernagelPeter MalliarasTjerk Sleeswijk VisserHakan AlfredsonInge van den Akker-ScheekMathijs van ArkAnnelie BrorssonRuth L ChimentiSean DockingPernilla EliassonKenneth FarnqvistZubair HaleemShawn L HanlonJean-Francois KauxRebecca Samantha KearneyPaul D KirwanKornelia KuligBhavesh KumarTrevor LewisUmile Giuseppe LongoTun Hing LuiNicola MaffulliAdrian James MallowsLorenzo MasciDennis McGonagleDylan MorrisseyMyles Calder MurphyRichard Newsham-WestKatarina Maria Nilsson-HelanderRichard NorrisFrancesco OlivaSeth O'NeillKoen PeersEbonie Kendra RioIgor SanchoAlexander ScottKayla D SeymoreSze-Ee SohPatrick VallanceJan A N VerhaarArco C van der VlistAdam WeirJennifer Ann ZellersBill T Vicenzino
Published in: British journal of sports medicine (2024)
To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement instruments, (2) an online survey on truth and feasibility of the available measurement instruments, (3) an assessment of the methodological quality of the selected outcome measurement instruments, (4) an online survey on the outcome measurement instruments as COS and (5) a consensus in-person meeting. Both surveys were completed by healthcare professionals and patients. The Outcome Measures in Rheumatology guidelines with a 70% threshold for consensus were followed. We identified 233 different outcome measurement instruments from 307 included studies; 177 were mapped within the International Scientific Tendinopathy Symposium Consensus core domains. 31 participants (12 patients) completed the first online survey (response rate 94%). 22/177 (12%) outcome measurement instruments were deemed truthful and feasible and their measurement properties were evaluated. 29 participants (12 patients) completed the second online survey (response rate 88%) and three outcome measurement instruments were endorsed: the Victorian Institute of Sports Assessment-Achilles questionnaire, the single-leg heel rise test and evaluating pain after activity using a Visual Analogue Scale (VAS, 0-10). 12 participants (1 patient) attended the final consensus meeting, and 1 additional outcome measurement instrument was endorsed: evaluating pain during activity/loading using a VAS (0-10). It is recommended that the identified COS-AT will be used in future clinical trials evaluating the effectiveness of an intervention. This will facilitate comparing outcomes of intervention strategies, data pooling and further progression of knowledge about AT. As COS-AT is implemented, further evidence on measurement properties of included measures and new outcome measurement instruments should lead to its review and refinement.
Keyphrases